Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880787013 | Crizanlizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3880788015 | Crizanlizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4699331000052119 | krizanlizumab | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crizanlizumab (substance) | Has disposition (attribute) | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
| Crizanlizumab (substance) | Is a | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
| Crizanlizumab (substance) | Is a | Monoclonal immunoglobulin G (substance) | true | Inferred relationship | Some | ||
| Crizanlizumab (substance) | Has disposition (attribute) | Immunomodulator (disposition) | true | Inferred relationship | Some | ||
| Crizanlizumab (substance) | Is a | murin-human monoklonal IgG-antikropp | false | Inferred relationship | Some | ||
| Crizanlizumab (substance) | Is a | Immunosuppressant (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only crizanlizumab (medicinal product) | Has active ingredient | True | Crizanlizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only crizanlizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Crizanlizumab (substance) | Inferred relationship | Some | 1 |
| Crizanlizumab-containing product in parenteral dose form | Has active ingredient | True | Crizanlizumab (substance) | Inferred relationship | Some | 1 |
| Product containing crizanlizumab (medicinal product) | Has active ingredient | True | Crizanlizumab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR